TDI
Live / Allowed — Published for opposition (as of 24 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99208486
- Mark type
- Stylized text
- Filed
- 29 May 2025
- Published for opposition
- 24 Feb 2026
- Attorney of record
- Devon E. White
Goods and services
- Class 035 — Advertising and business services: Database management and data processing services in the pharmaceutical and life sciences fields; business data analytics and data management services being data processing for business purposes in the pharmaceutical and life sciences fields of clinical research; Business consulting and management in the field of clinical trials, namely, clinical data management on behalf of pharmaceutical and life sciences companies to assist them with clinical research and clinical trials; Providing independent review of clinical trial data for clinical trial purposes for business purposes
- Class 042 — Scientific and technological services: Scientific data analysis, namely, analysis of clinical trial data in the pharmaceutical, biotechnology and life sciences fields; Scientific research services, namely, accessing, collecting, managing, tracking, analyzing, and reporting research data in the pharmaceutical and life sciences fields; Scientific research consulting services, namely, collecting, managing, and analyzing clinical trial data; Consulting services for others in the field of design, planning, and implementation of clinical trials, clinical trial simulation, and clinical trial data review; Contract research organization (CRO) services, namely, scientific research in the nature of conducting clinical trials for investigational drugs of biotech and pharmaceutical companies for others, and quality assurance services for others in the fields of data management, electronic data capture (EDC) database programming of clinical trial, and data analytics for others; Consulting services in the field of conducting clinical trials in the pharmaceutical industry and the biotechnology industry; Providing quality assurance services in the pharmaceutical and biotechnology fields for others
Owner
- APERIO CLINICAL OUTCOMES LLC, Durham, NC, US
- APERIO CLINICAL OUTCOMES LLC, Durham, NC, US
Prosecution history
- 24 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Feb 2026 — PUBLISHED FOR OPPOSITION
- 18 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Oct 2025 — NON-FINAL ACTION E-MAILED
- 17 Oct 2025 — NON-FINAL ACTION WRITTEN
- 17 Oct 2025 — ASSIGNED TO EXAMINER
- 06 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 29 May 2025 — APPLICATION FILING RECEIPT MAILED
- 29 May 2025 — NEW APPLICATION ENTERED